MAP2K7 and melanoma: Treatment of VMM18 melanoma cells with a 10 nM dose of BAY 43-9006 produced a 75% decrease in the dual phosphorylation of ERK (Figure 5, lane 4) and reduced the phosphorylation of MEK below detection levels (not shown).